Purpose: We recently reported that anionic phospholipids, principally phosphatidylserine, become exposed on the external surface of vascular endothelial cells in tumors, probably in response to oxidative stresses present in the tumor microenvironment. In the present study, we tested the hypothesis that a chimeric monoclonal antibody that binds phosphatidylserine could be labeled with radioactive arsenic isotopes and used for molecular imaging of solid tumors in rats. As (h -,T 1/2 1.6 days) using a novel procedure. The radionuclides of arsenic were selected because their long half-lives are consistent with the long biological half lives of antibodies in vivo and because their chemistry permits stable attachment to antibodies. The radiolabeled antibodies were tested for the ability to image subcutaneous Dunning prostate R3227-AT1tumors in rats. Results: Clear images of the tumors were obtained using planar g-scintigraphy and positron emission tomography. Biodistribution studies confirmed the specific localization of bavituximab to the tumors. The tumor-to-liver ratio 72 h after injection was 22 for bavituximab compared with 1.5 for an isotype-matched control chimeric antibody of irrelevant specificity. Immunohistochemical studies showed that the bavituximab was labeling the tumor vascular endothelium. Conclusions: These results show that radioarsenic-labeled bavituximab has potential as a new tool for imaging the vasculature of solid tumors.

No abstract

No abstract

No abstract

Charged-particle cross section database for medical radioisotope production was developed under an international project coordinated by the lAEA. The project focused on radioisotopes for diagnostic purposes and on the related beam monitor reactions. The database contains activation cross-sections of reactions induced by light charged particles with energies mostly up to about 40 MeV. It includes 22 beam monitor reactions for protons (8), deuterons (5),3He (3) and a-particles (6), and 26 reactions for most commonly used ,-emitters (12), their serious isotopic impurities (4) and (3+ -emitters (10).

No abstract

Activation cross sections of proton induced nuclear reactions on palladium were measured up to 80 MeV by using the stacked foil irradiation technique and gamma ray spectrometry. The beam intensity, the incident energy and the energy degradation were controlled by a method based on flux constancy via normalization to the excitation functions of monitor reactions measured in parallel. Excitation functions for direct and cumulative cross-sections were measured for the production of 104m,104g,105g,106m,110m Ag, 100,101 Pd, 99m,99g,100,101m,101g,102m,102g,105 Rh and 103,97 Ru radioisotopes. The cross section data were compared with the theoretical predictions of TENDL-2014 and -2015 libraries. For practical applications thick target yields were derived from the measured excitation functions. Application in the field of medical radionuclide production is shortly discussed.

No abstract